Vascular endothelial growth factor of the lung: friend or foe

被引:54
|
作者
Tuder, Rubin M. [1 ]
Yun, Jeong H. [1 ]
机构
[1] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm & Crit Care Med,Dept Med, Denver, CO 80262 USA
关键词
D O I
10.1016/j.coph.2008.03.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The discovery of vascular endothelial growth factor (VEGF) changed the field of angiogenesis. We have learned that VEGF has broader actions than merely a driver of tumor angiogenesis, particularly that VEGF controlled several fundamental functions and properties of endothelial cells and nonendothelial cells. The lung is one of the main organs where VEGF controls several crucial physiological functions. These actions rely on tightly regulated temporal and concentration gradients of VEGF and VEGF receptor expression in the lung. Excessive or diminished VEGF have been linked to abnormal lung phenotypes and, in humans, linked to several diseases. The beneficial and detrimental actions of VEGF underscore that therapeutic targeting of VEGF in disease has to carefully consider the lung biology of VEGF.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [21] Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung
    Michelle Sands
    Katherine Howell
    Christine M Costello
    Paul McLoughlin
    Respiratory Research, 12
  • [22] Leptin and vascular function: friend or foe?
    Wolk, Robert
    Somers, Virend K.
    EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2263 - 2265
  • [23] Vascular endothelial growth factor polymorphisms and lung cancer risk
    Fan, Junli
    Zhang, Weiguo
    Lei, Caipeng
    Qiao, Bin
    Liu, Qin
    Chen, Qiang
    Jiao, Hongduo
    Jiang, Leizhen
    Cui, Shuo
    Chen, Jianmin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6406 - 6411
  • [24] Vascular endothelial growth factor expression in lung cancer.
    O'Byrne, KJ
    Giatromanolaki, A
    Koukourakis, MI
    Turley, H
    Scott, PAE
    Pezzella, F
    Harris, AL
    Gatter, KC
    BRITISH JOURNAL OF CANCER, 1998, 78 : 47 - 47
  • [25] VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
    Barratt, Shaney L.
    Flower, Victoria A.
    Pauling, John D.
    Millar, Ann B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [26] Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
    Carmeliet, P
    Collen, D
    VASCULAR GROWTH FACTORS AND ANGIOGENESIS, 1999, 237 : 133 - 158
  • [27] Expression Of Vascular Endothelial Growth Factor (VEGF) And Vascular Endothelial Growth Factor Receptors (VEGFRs) In Lung Tissue Of Smokers And COPD Patients
    Lee, S. H.
    Lee, E. J.
    Hur, G. Y.
    Lee, S. Y.
    Lee, S. Y.
    Kim, J. H.
    Shin, C.
    Shim, J. J.
    In, K. H.
    Kang, K. H.
    Yoo, S. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [28] The mitochondria in lung fibrosis: friend or foe?
    Malsin, Elizabeth S.
    Kamp, David W.
    TRANSLATIONAL RESEARCH, 2018, 202 : 1 - 23
  • [29] Autophagy: Friend or Foe in Lung Disease?
    Mizumura, Kenji
    Cloonan, Suzanne
    Choi, Mary E.
    Hashimoto, Shu
    Nakahira, Kiichi
    Ryter, Stefan W.
    Choi, Augustine M. K.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 : S40 - S47
  • [30] Lung inflammation in ARDS - Friend or foe?
    Suter, PM
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16): : 1739 - 1742